New treatment option for Carpal Tunnel Syndrome
Official title Ultrasound-Guided Carpal Tunnel Infiltration: Comparison Between the Manual Method and a Robot-Assisted Method
ClinicalTrials.gov ID: NCT07334964
What this study is testing
- What it's testing
- This study aims to assess the feasibility, safety, and accuracy of a robotic arm-assisted carpal tunnel injection in comparison with the conventional ultrasound-guided method, prior to conducting a larger-scale study. The use of a robotic arm to maintain the ultrasound probe in position could provide valuable assistance to the physician.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Age ≥ 18 and ≤ 75 years.
- Clinical diagnosis of carpal tunnel syndrome.
- Indication for corticosteroid injection as determined by investigator.
- Moderate to severe carpal tunnel syndrome defined by a pain score on the Visual Analogue Scale (VAS) ≥ 4 (at baseline and on day 0).
- Signed informed consent.
You likely can't join if
- Known allergy to corticosteroids or povidone-iodine (Betadine)
- Probable or ongoing systemic or local infection
- History of injection in the affected wrist within the last 6 months
- Thenar eminence atrophy
- Trauma requiring surgery or immobilization
- History of carpal tunnel surgery
See the full eligibility criteria
- Age ≥ 18 and ≤ 75 years.
- Clinical diagnosis of carpal tunnel syndrome.
- Indication for corticosteroid injection as determined by investigator.
- Moderate to severe carpal tunnel syndrome defined by a pain score on the Visual Analogue Scale (VAS) ≥ 4 (at baseline and on day 0).
- Signed informed consent.
- Known allergy to corticosteroids or povidone-iodine (Betadine)
- Probable or ongoing systemic or local infection
- History of injection in the affected wrist within the last 6 months
- Thenar eminence atrophy
- Trauma requiring surgery or immobilization
- History of carpal tunnel surgery
- Protected person (under guardianship or curatorship)
- Person under judicial protection
- Person deprived of liberty
- Person not affiliated with a social security scheme
- Pregnant or breastfeeding woman
- Person participating in a drug trial
The study team makes the final eligibility decision.
Where it's taking place
- Orléans, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Orléans, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.